Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAxcBog2Q4xaOKHpaM2M4Y9HszuR2ieYbHEVgHLTa9CC0#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _5 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion hadPrimarySource 14587863 provenance.
- _4 wasQuotedFrom 14587863 provenance.
- _4 value "JAK/STATs C225 Phase I treatment (47) AG490 Preclinical treatment (48-51) #----------------------------------------------------------------- Table II. Chemopreventive Agents for Targeting Signal Transduction Pathways Target Drug Phase of Testing Reference Cox-2 Celecoxib Preclinical treatment (164,174-177) and prevention Nimesulide, Valdecoxib, Preclinical treatment (178) Parecoxib, Etoricoxib, Lumaricoxib Sulindac Phase II treatment (179-181) Exisulind Phase I treatment" provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.